In the last decades we have witnessed a revolution in the lung cancer care that has moved from a mass cancer-center conception to the idea that each patient has unique signature. The multidisciplinary integrative approach nowadays combined different professionalism that can contribute with different approach to create a patient’s overall treatment plan that combines the best options for its disease. The medicine nowadays, thanks to the molecular discovery and digital revolution, has transformed the approach to a medicine, which is predictive, preventive and personalized. The strong impetus determined by all the new technologies and learn about lung cancer biology has generated optimism in lung cancer fight, useful for feeding new discoveries.
This focused issue aims to include the innovations in the field, so as to provide comprehensive and deep thinking about lung cancer care to specialists all around the world, which we hope will also be conducive to patients as well as the growth of young surgeons.
A new era in lung cancer care: from early diagnosis to personalized treatment
Big Data and machine learning: new frontier in lung cancer care
Early diagnosis with alternative approaches: innovation in lung cancer care
Translational new frontiers in lung cancer research
Pushing the boundaries: transesophageal endoscopic ultrasound-guided fine-needle aspiration for the diagnosis of intraparenchymal pulmonary micronodules
One’s learning is never complete: chronic high-pressure life-treating pleural effusion in post-pneumonectomy patients
Stem cells for lung cancer: impacts and future developments
Disclosure:
The series “A New Era in Lung Cancer Care: from Early Diagnosis to Personalized Treatment” was commissioned by the editorial office, Shanghai Chest without any sponsorship or funding. Giulia Sedda and Roberto Gasparri served as the unpaid Guest Editors for the series.